跳至主要内容
临床试验/JPRN-UMIN000003162
JPRN-UMIN000003162已完成2 期

A romdomized controlled study of effectiveness between transcatheter arterial chemoembolization with cisplatin and transcatheter arterial chemoembolization with epirubicin for multiple hepatocellular carcinomas - A romdomized controlled study of effectiveness between CDDP-TACE and EPI-TACE for multiple HCCs

Department of Surgery, Graduate School of Medicine Kyoto Uinversity0 个研究点目标入组 160 人开始时间: 2010年4月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with another active cancer 2)Patients with extrahepatic metastasis 3)Patients with prior surgical reconstruction of the biliary tract or prior endoscopic treatment of ampulla of vater 4)Patients with clinically significant refractory ascites or pleural effusion 5)Patients with hepatic encephalopathy 6)Patients with severe co-morbidity such as cardiac failure and renal failure 7) Patients who have taken doses of chemotherapeutic agents with cardiac toxicity exceeding a set threshold. 8)Patients with a medical history of severe hypersensitivity 9)Patients who are pregnant, lactating or are suspected to be pregnant. 10)Patients who are concluded to be inappropriate to participate in this study by their physicians

研究者

发起方
Department of Surgery, Graduate School of Medicine Kyoto Uinversity

相似试验